Holen Sie sich die Stockscreener-App
5.08
3.67%
0.18
Schlusskurs vom Vortag:
$4.90
Offen:
$4.89
24-Stunden-Volumen:
393.23K
Relative Volume:
0.59
Marktkapitalisierung:
$211.29M
Einnahmen:
$134.48M
Nettoeinkommen (Verlust:
$-38.94M
KGV:
-5.3283
EPS:
-0.9534
Netto-Cashflow:
$-19.34M
1W Leistung:
+12.64%
1M Leistung:
+4.74%
6M Leistung:
-29.44%
1J Leistung:
-39.74%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$4.45
$5.09
52-Wochen-Spanne:
$4.40
$13.22
Rxsight Inc Stock (RXST) Company Profile
Firmenname
Rxsight Inc
Sektor
Branche
Telefon
949-521-7822
Adresse
100 COLUMBIA STREET, ALISO VIEJO
Compare RXST vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RXST
Rxsight Inc
|
5.08 | 211.29M | 134.48M | -38.94M | -19.34M | -0.9534 |
ABT
Abbott Laboratories
|
102.51 | 177.38B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
96.59 | 123.55B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
307.08 | 117.79B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
46.01 | 66.68B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.09 | 51.93B | 6.30B | 1.07B | 1.09B | 1.8406 |
Rxsight Inc Stock (RXST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-30 | Eingeleitet | William Blair | Mkt Perform |
| 2025-07-15 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-07-10 | Herabstufung | Jefferies | Buy → Hold |
| 2025-07-09 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-07-09 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-07-09 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-05-19 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-04-15 | Eingeleitet | Piper Sandler | Neutral |
| 2025-04-09 | Herabstufung | UBS | Buy → Neutral |
| 2025-04-04 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2025-04-03 | Herabstufung | BofA Securities | Buy → Underperform |
| 2024-12-20 | Herabstufung | Stifel | Buy → Hold |
| 2024-12-11 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-12-06 | Eingeleitet | UBS | Buy |
| 2024-10-29 | Eingeleitet | Jefferies | Buy |
| 2024-08-20 | Bestätigt | Needham | Buy |
| 2024-08-06 | Bestätigt | Needham | Buy |
| 2024-05-07 | Bestätigt | BTIG Research | Buy |
| 2023-12-13 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-12-12 | Eingeleitet | Stifel | Buy |
| 2023-12-04 | Eingeleitet | Morgan Stanley | Overweight |
| 2023-04-13 | Eingeleitet | Oppenheimer | Outperform |
| 2022-12-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-08 | Eingeleitet | Needham | Buy |
Alle ansehen
Rxsight Inc Aktie (RXST) Neueste Nachrichten
K2 Vision Has Been Recognized as the Highest-Volume Light Adjustable Lens practice in the world - GlobeNewswire Inc.
RxSight Inc. (RXST) Ticks Higher: Shares Gain 2.14% to Close at $4.77Dealer Delta - https://www.siam.in/
RxSight, Inc. (RXST) insider now holds 235,516 shares after option exercise - Stock Titan
The Technical Signals Behind (RXST) That Institutions Follow - Stock Traders Daily
Alcon, RxSight Form Collaboration to Develop Adjustable PCIOLs - Medical Product Outsourcing
RxSight (NASDAQ: RXST) CFO swaps 258K options, cuts strike to $6.375 with no share change - Stock Titan
RxSight (NASDAQ: RXST) COO swaps high-priced options for new $6.375 grants - Stock Titan
RxSight (RXST) CMO exchanges higher-priced options for new $6.375 grants - Stock Titan
RxSight (NASDAQ:RXST) Faces a Crucial Test on the Road to Scale - Kalkine Media
RxSight at wells fargo healthcare conference: reset centers on LAL growth - Investing.com Canada
RxSight at wells fargo healthcare conference: reset centers on LAL growth - Investing.com India
RxSight at wells fargo healthcare conference: reset centers on LAL growth - Investing.com UK
RxSight (RXST) resets exec stock options to $6.375 - Stock Titan
RxSight (RXST) ends employee option swap after 91.9% take-up - Stock Titan
RXST Form 4 FilingsRxSight, Inc. SEC Form 4 - Stock Titan
RXST stock slips as insider selling and cash level draw attention - AD HOC NEWS
RxSight Officer Mark Wilterding to Sell 7,765 Shares Worth $54,044.40 to Cover Tax Withholding - Kalkine Media
RxSight stock edges higher after insider tax sales and Q2 beat - ad-hoc-news.de
RxSight CFO Mark Wilterding sells $54,044 in company stock By Investing.com - Investing.com South Africa
RxSight COO Ilya Goldshleger sells $14,205 in company stock By Investing.com - Investing.com South Africa
RxSight COO Ilya Goldshleger sells $14,205 in company stock By Investing.com - Investing.com Australia
RxSight CMO Ronald Kurtz sells $35,496 in shares for tax By Investing.com - Investing.com Australia
RxSight CFO Mark Wilterding sells $54,044 in company stock By Investing.com - Investing.com Canada
RxSight CFO Mark Wilterding sells $54,044 in company stock - Investing.com
RxSight COO Ilya Goldshleger sells $14,205 in company stock - Investing.com
RxSight CMO Ronald Kurtz sells $35,496 in shares for tax By Investing.com - Investing.com Canada
RxSight CFO Mark Wilterding sells $54,044 in company stock By Investing.com - Investing.com Nigeria
RxSight CMO Ronald Kurtz sells $35,496 in shares for tax - Investing.com India
RxSight CFO Mark Wilterding sells $54,044 in company stock By Investing.com - Investing.com UK
RxSight chief business development officer Eric Weinberg sells $14,205 in stock - Investing.com
RxSight chief business development officer Eric Weinberg sells $14,205 in stock - Investing.com Canada
RxSight chief business development officer Eric Weinberg sells $14,205 in stock - Investing.com India
RxSight (NASDAQ: RXST) officer plans 5,100-share sale to cover taxes - Stock Titan
RSU vesting at RxSight (NASDAQ: RXST) prompts insider share sale - Stock Titan
RxSight (RXST) officer to sell shares for taxes - Stock Titan
RxSight (RXST) CFO sells shares to cover RSU taxes - Stock Titan
RxSight (RXST) CMO vests 13,425 units, sells shares for taxes - Stock Titan
RxSight (RXST) COO sells 2,041 shares after RSU vest - Stock Titan
RxSight (RXST) exec’s stock sale only covers taxes - Stock Titan
Price to earnings forward of RxSight, Inc. – NASDAQ:RXST - TradingView
(RXST) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
RxSight (RXST) officer to sell 5,370 shares for RSU taxes - Stock Titan
RxSight stock holds in the lower single digits as losses narrow on stronger quarterly revenue - ad-hoc-news.de
RxSight, Inc. to Participate in the Wells Fargo Healthcare Conference - Yahoo Finance
RxSight (NASDAQ: RXST) refreshes documents for option exchange - Stock Titan
Tocqueville Asset Management L.P. Makes New Investment in RxSight, Inc. $RXST - MarketBeat
Steven Cohen’s Point72 discloses RxSight (RXST) stake - Stock Titan
RxSight (RXST) Q2 2026 Results: The Bottom-Line Figure Outpaces Its Comparison at the Close; Price Move - vinanet.vn
RxSight (RXST) Market: Moves 1.88% Higher to $6.49 in the Current Update; Boundary Watch: Support at $6.17 and Resistance at $6.81 Frame the Range on the DayATR Trailing Stop - vinanet.vn
Vitruvian Partners LLP Purchases New Holdings in RxSight, Inc. $RXST - MarketBeat
Finanzdaten der Rxsight Inc-Aktie (RXST)
Umsatz
Nettogewinn
Free Cashflow
ENV
Rxsight Inc-Aktie (RXST) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Weinberg Eric | See remarks |
Sep 02 '26 |
Sale |
6.96 |
2,041 |
14,205 |
200,348 |
| Kurtz Ronald M MD | Officer |
Sep 02 '26 |
Proposed Sale |
6.96 |
5,100 |
35,496 |
0 |
| Wilterding Mark | Officer |
Sep 02 '26 |
Proposed Sale |
6.96 |
7,765 |
54,044 |
0 |
| Goldshleger Ilya | Officer |
Sep 02 '26 |
Proposed Sale |
6.96 |
2,041 |
14,205 |
0 |
| Weinberg Eric | Officer |
Sep 02 '26 |
Proposed Sale |
6.96 |
2,041 |
14,205 |
0 |
| Kurtz Ronald M MD | Chief Medical Officer |
Sep 02 '26 |
Sale |
6.96 |
5,100 |
35,496 |
71,775 |
| Wilterding Mark | Chief Financial Officer |
Sep 02 '26 |
Sale |
6.96 |
7,765 |
54,044 |
25,049 |
| Goldshleger Ilya | Chief Operating Officer |
Sep 02 '26 |
Sale |
6.96 |
2,041 |
14,205 |
81,509 |
| RAYMOND W COHEN | Former Director |
Aug 18 '26 |
Proposed Sale |
6.37 |
11,890 |
75,749 |
0 |
| Goldshleger Ilya | Chief Operating Officer |
Apr 17 '26 |
Option Exercise |
4.13 |
12,489 |
51,580 |
78,180 |
1.23%
1.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):